BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lina TT, Alzahrani S, Gonzalez J, Pinchuk IV, Beswick EJ, Reyes VE. Immune evasion strategies used by Helicobacter pyloriWorld J Gastroenterol 2014; 20(36): 12753-12766 [PMID: 25278676 DOI: 10.3748/wjg.v20.i36.12753] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Bosschem I, Flahou B, Van Deun K, De Koker S, Volf J, Smet A, Ducatelle R, Devriendt B, Haesebrouck F. Species-specific immunity to Helicobacter suis. Helicobacter 2017;22:e12375. [DOI: 10.1111/hel.12375] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
2 Boer MC, Joosten SA, Ottenhoff TH. Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination. Front Immunol 2015;6:217. [PMID: 26029205 DOI: 10.3389/fimmu.2015.00217] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 11.3] [Reference Citation Analysis]
3 Kim N. Immunological Reactions on H. pylori Infection. In: Kim N, editor. Helicobacter pylori. Singapore: Springer; 2016. pp. 35-52. [DOI: 10.1007/978-981-287-706-2_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Eberhardt KA, Sarfo FS, Dompreh A, Kuffour EO, Geldmacher C, Soltau M, Schachscheider M, Drexler JF, Eis-Hübinger AM, Häussinger D, Bedu-Addo G, Phillips RO, Norman B, Burchard GD, Feldt T. Helicobacter pylori Coinfection Is Associated With Decreased Markers of Immune Activation in ART-Naive HIV-Positive and in HIV-Negative Individuals in Ghana. Clin Infect Dis 2015;61:1615-23. [PMID: 26195015 DOI: 10.1093/cid/civ577] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
5 Gupta N, Maurya S, Verma H, Verma VK. Unraveling the factors and mechanism involved in persistence: Host-pathogen interactions in Helicobacter pylori. J Cell Biochem. 2019;120:18572-18587. [PMID: 31237031 DOI: 10.1002/jcb.29201] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
6 Wang A, Yerxa J, Agarwal S, Turner MC, Schroder V, Youngwirth LM, Lagoo-Deenadayalan S, Pappas TN. Surgical management of peptic ulcer disease. Curr Probl Surg 2020;57:100728. [PMID: 32138833 DOI: 10.1016/j.cpsurg.2019.100728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Eed EM, Hawash YA, Khalifa AS, Alsharif KF, Alghamdi SA, Saber T, Ismail KA, Shehab-Eldeen SA. Molecular diagnosis of Helicobacter pylori antibiotic resistance in the Taif region, Saudi Arabia. Microbiol Immunol 2019;63:199-205. [PMID: 31045263 DOI: 10.1111/1348-0421.12686] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
8 Gu H. Role of Flagella in the Pathogenesis of Helicobacter pylori. Curr Microbiol. 2017;74:863-869. [PMID: 28444418 DOI: 10.1007/s00284-017-1256-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
9 Gonciarz W, Krupa A, Hinc K, Obuchowski M, Moran AP, Gajewski A, Chmiela M. The effect of Helicobacter pylori infection and different H. pylori components on the proliferation and apoptosis of gastric epithelial cells and fibroblasts. PLoS One 2019;14:e0220636. [PMID: 31390383 DOI: 10.1371/journal.pone.0220636] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
10 Wang Z, Vaughan TY, Zhu W, Chen Y, Fu G, Medrzycki M, Nishio H, Bunting ST, Hankey-Giblin PA, Nusrat A, Parkos CA, Wang D, Wen R, Bunting KD. Gab2 and Gab3 Redundantly Suppress Colitis by Modulating Macrophage and CD8+ T-Cell Activation. Front Immunol 2019;10:486. [PMID: 30936879 DOI: 10.3389/fimmu.2019.00486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Luong HX, Thanh TT, Tran TH. Antimicrobial peptides - Advances in development of therapeutic applications. Life Sci 2020;260:118407. [PMID: 32931796 DOI: 10.1016/j.lfs.2020.118407] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
12 Liu Y, Shuai P, Liu YP, Li DY. Association between Helicobacter pylori infection and food-specific immunoglobulin G in Southwest China. World J Clin Cases 2021; 9(32): 9815-9824 [PMID: 34877320 DOI: 10.12998/wjcc.v9.i32.9815] [Reference Citation Analysis]
13 Suarez G, Romero-Gallo J, Sierra JC, Piazuelo MB, Krishna US, Gomez MA, Wilson KT, Peek RM. Genetic Manipulation of Helicobacter pylori Virulence Function by Host Carcinogenic Phenotypes. Cancer Res. 2017;77:2401-2412. [PMID: 28209611 DOI: 10.1158/0008-5472.can-16-2922] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
14 Ebrahimi A, Soofizadeh B, Ebrahimi F, Moaadab SY, Bonyadi M, Gojazadeh M, Malek Mahdavi A. Relationship between Helicobacter pylori cytotoxin-associated gene A protein with clinical outcomes in patients with rheumatoid arthritis. Immunol Lett 2019;211:49-52. [PMID: 31150676 DOI: 10.1016/j.imlet.2019.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Shen Z, Dzink-Fox J, Feng Y, Muthupalani S, Mannion AJ, Sheh A, Whary MT, Holcombe HR, Piazuelo BM, Bravo LE, Josenhans C, Suerbaum S, Wilson KT, Peek RM, Wang TC, Fox JG. Gastric Non-Helicobacter pylori Urease-Positive Staphylococcus epidermidis and Streptococcus salivarius Isolated from Humans Have Contrasting Effects on H. pylori-Associated Gastric Pathology and Host Immune Responses in a Murine Model of Gastric Cancer. mSphere 2022;:e0077221. [PMID: 35138124 DOI: 10.1128/msphere.00772-21] [Reference Citation Analysis]
16 Farjadian S, Tabebordbar M, Mokhtari M, Safaei A, Malekzadeh M, Ghaderi A. HLA-G Expression in Tumor Tissues and Soluble HLA-G Plasma Levels in Patients with Gastrointestinal Cancer. Asian Pac J Cancer Prev 2018;19:2731-5. [PMID: 30360598 DOI: 10.22034/APJCP.2018.19.10.2731] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
17 Steiner TM, Lettl C, Schindele F, Goebel W, Haas R, Fischer W, Eisenreich W. Substrate usage determines carbon flux via the citrate cycle in Helicobacter pylori. Mol Microbiol 2021. [PMID: 34164854 DOI: 10.1111/mmi.14775] [Reference Citation Analysis]
18 Hossain MJ, Morandi E, Tanasescu R, Frakich N, Caldano M, Onion D, Faraj TA, Erridge C, Gran B. The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker. Front Immunol 2018;9:457. [PMID: 29593720 DOI: 10.3389/fimmu.2018.00457] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
19 Cheok YY, Lee CYQ, Cheong HC, Vadivelu J, Looi CY, Abdullah S, Wong WF. An Overview of Helicobacter pylori Survival Tactics in the Hostile Human Stomach Environment. Microorganisms 2021;9:2502. [PMID: 34946105 DOI: 10.3390/microorganisms9122502] [Reference Citation Analysis]
20 Kinnear C, Moore TL, Rodriguez-lorenzo L, Rothen-rutishauser B, Petri-fink A. Form Follows Function: Nanoparticle Shape and Its Implications for Nanomedicine. Chem Rev 2017;117:11476-521. [DOI: 10.1021/acs.chemrev.7b00194] [Cited by in Crossref: 243] [Cited by in F6Publishing: 181] [Article Influence: 48.6] [Reference Citation Analysis]
21 Mohammadi A, Khanbabaei H, Zandi F, Ahmadi A, Haftcheshmeh SM, Johnston TP, Sahebkar A. Curcumin: A therapeutic strategy for targeting the Helicobacter pylori-related diseases. Microbial Pathogenesis 2022. [DOI: 10.1016/j.micpath.2022.105552] [Reference Citation Analysis]
22 Capparelli R, Iannelli D. Genetics of Host Protection against Helicobacter pylori Infections. Int J Mol Sci 2021;22:3192. [PMID: 33801073 DOI: 10.3390/ijms22063192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Wu X, Jian A, Tang H, Liu W, Liu F, Liu S, Wu H. A Multi-Omics Study on the Effect of Helicobacter Pylori-Related Genes in the Tumor Immunity on Stomach Adenocarcinoma. Front Cell Infect Microbiol 2022;12:880636. [DOI: 10.3389/fcimb.2022.880636] [Reference Citation Analysis]
24 Rezalotfi A, Ahmadian E, Aazami H, Solgi G, Ebrahimi M. Gastric Cancer Stem Cells Effect on Th17/Treg Balance; A Bench to Beside Perspective. Front Oncol. 2019;9:226. [PMID: 31024835 DOI: 10.3389/fonc.2019.00226] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
25 Shafiee A, Amini M, Emamirad H, Talebi Bezmin Abadi A. Recombination and phenotype evolution dynamic of Helicobacter pylori in colonized hosts. Int J Syst Evol Microbiol. 2016; Epub ahead of print. [PMID: 27082852 DOI: 10.1099/ijsem.0.001072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
26 McNees AL, Markesich D, Zayyani NR, Graham DY. Mycobacterium paratuberculosis as a cause of Crohn's disease. Expert Rev Gastroenterol Hepatol 2015;9:1523-34. [PMID: 26474349 DOI: 10.1586/17474124.2015.1093931] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 9.1] [Reference Citation Analysis]
27 Lérias JR, Paraschoudi G, de Sousa E, Martins J, Condeço C, Figueiredo N, Carvalho C, Dodoo E, Castillo-Martin M, Beltrán A, Ligeiro D, Rao M, Zumla A, Maeurer M. Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies. Front Cell Dev Biol 2019;7:362. [PMID: 32039196 DOI: 10.3389/fcell.2019.00362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Stenström B, Windsor HM, Fulurija A, Benghezal M, Kumarasinghe MP, Kimura K, Tay CY, Viiala CH, Ee HC, Lu W, Schoep TD, Webberley KM, Marshall BJ. Helicobacter pylori overcomes natural immunity in repeated infections. Clin Case Rep 2016;4:1026-33. [PMID: 27830066 DOI: 10.1002/ccr3.687] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
29 Saxena K, Chauhan N, Jain U. Advances in diagnosis of Helicobacter pylori through biosensors: Point of care devices. Anal Biochem 2021;630:114325. [PMID: 34352253 DOI: 10.1016/j.ab.2021.114325] [Reference Citation Analysis]
30 Holokai L, Chakrabarti J, Broda T, Chang J, Hawkins JA, Sundaram N, Wroblewski LE, Peek RM Jr, Wang J, Helmrath M, Wells JM, Zavros Y. Increased Programmed Death-Ligand 1 is an Early Epithelial Cell Response to Helicobacter pylori Infection. PLoS Pathog 2019;15:e1007468. [PMID: 30703170 DOI: 10.1371/journal.ppat.1007468] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 18.7] [Reference Citation Analysis]
31 Sijmons D, Guy AJ, Walduck AK, Ramsland PA. Helicobacter pylori and the Role of Lipopolysaccharide Variation in Innate Immune Evasion. Front Immunol 2022;13:868225. [DOI: 10.3389/fimmu.2022.868225] [Reference Citation Analysis]
32 Chmiela M, Karwowska Z, Gonciarz W, Allushi B, Stączek P. Host pathogen interactions in Helicobacter pylori related gastric cancer. World J Gastroenterol 2017; 23(9): 1521-1540 [PMID: 28321154 DOI: 10.3748/wjg.v23.i9.1521] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 46] [Article Influence: 9.8] [Reference Citation Analysis]
33 Coletta S, Battaggia G, Della Bella C, Furlani M, Hauke M, Faass L, D'Elios MM, Josenhans C, de Bernard M. ADP-heptose enables Helicobacter pylori to exploit macrophages as a survival niche by suppressing antigen-presenting HLA-II expression. FEBS Lett 2021. [PMID: 34216493 DOI: 10.1002/1873-3468.14156] [Reference Citation Analysis]
34 Karkhah A, Ebrahimpour S, Rostamtabar M, Koppolu V, Darvish S, Vasigala VKR, Validi M, Nouri HR. Helicobacter pylori evasion strategies of the host innate and adaptive immune responses to survive and develop gastrointestinal diseases. Microbiol Res 2019;218:49-57. [PMID: 30454658 DOI: 10.1016/j.micres.2018.09.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
35 Park JM, Han YM, Hwang SJ, Kim SJ, Hahm KB. Therapeutic effects of placenta derived-, umbilical cord derived-, and adipose tissue derived-mesenchymal stem cells in chronic Helicobacter pylori infection: comparison and novel mechanisms. J Clin Biochem Nutr 2021;69:188-202. [PMID: 34616110 DOI: 10.3164/jcbn.20-151] [Reference Citation Analysis]
36 Chang CC, Kuo WS, Chen YC, Perng CL, Lin HJ, Ou YH. Fragmentation of CagA Reduces Hummingbird Phenotype Induction by Helicobactor pylori. PLoS One 2016;11:e0150061. [PMID: 26934189 DOI: 10.1371/journal.pone.0150061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
37 Ravishankar Ram M, Goh KL, Leow AH, Poh BH, Loke MF, Harrison R, Shankar EM, Vadivelu J. Polymorphisms at Locus 4p14 of Toll-Like Receptors TLR-1 and TLR-10 Confer Susceptibility to Gastric Carcinoma in Helicobacter pylori Infection. PLoS One 2015;10:e0141865. [PMID: 26559190 DOI: 10.1371/journal.pone.0141865] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
38 Chulkina M, Beswick EJ, Pinchuk IV. Role of PD-L1 in Gut Mucosa Tolerance and Chronic Inflammation. Int J Mol Sci 2020;21:E9165. [PMID: 33271941 DOI: 10.3390/ijms21239165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Xie W, Zhao W, Zou Z, Kong L, Yang L. Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice. Helicobacter 2021;26. [DOI: 10.1111/hel.12807] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Zhang X, Liu CJ. Immune response and immune escape mechanism in Helicobacter pylori infection. Shijie Huaren Xiaohua Zazhi 2018; 26(31): 1832-1842 [DOI: 10.11569/wcjd.v26.i31.1832] [Reference Citation Analysis]
41 Hock BD, McKenzie JL, Keenan JI. Helicobacter pylori outer membrane vesicles inhibit human T cell responses via induction of monocyte COX-2 expression. Pathog Dis. 2017;75:ftx034. [PMID: 28430970 DOI: 10.1093/femspd/ftx034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
42 Meier HCS, Miller FW, Dinse GE, Weinberg CR, Cho CC, Parks CG. Helicobacter pylori seropositivity is associated with antinuclear antibodies in US adults, NHANES 1999-2000. Epidemiol Infect 2020;148:e20. [PMID: 32019616 DOI: 10.1017/S0950268820000126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Jain U, Saxena K, Chauhan N. Helicobacter pylori induced reactive oxygen Species: A new and developing platform for detection. Helicobacter 2021;26:e12796. [PMID: 33666321 DOI: 10.1111/hel.12796] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Bauwens E, Joosten M, Taganna J, Rossi M, Debraekeleer A, Tay A, Peters F, Backert S, Fox J, Ducatelle R, Remaut H, Haesebrouck F, Smet A. In silico proteomic and phylogenetic analysis of the outer membrane protein repertoire of gastric Helicobacter species. Sci Rep 2018;8:15453. [PMID: 30337679 DOI: 10.1038/s41598-018-32476-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
45 Song M, Rabkin CS, Torres J, Kemp TJ, Zabaleta J, Pinto LA, Hildesheim A, Sánchez-Figueroa L, Guarner J, Herrera-Goepfert R, Parsonnet J, Camargo MC. Circulating inflammation-related markers and advanced gastric premalignant lesions. J Gastroenterol Hepatol 2019;34:852-6. [PMID: 30357905 DOI: 10.1111/jgh.14518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
46 赵丽梅, 冯志杰. 幽门螺杆菌感染与心血管疾病. 世界华人消化杂志 2017; 25(14): 1255-1264 [DOI: 10.11569/wcjd.v25.i14.1255] [Reference Citation Analysis]
47 Genre J, Reginaldo FP, Andrade JM, Lima FP, da Camara AV, Donadi EA, Crispim JC. HLA-G 14-bp Ins/Ins Genotype in Patients Harbouring Helicobacter pylori Infection: A Potential Risk Factor? Scand J Immunol 2016;83:52-7. [PMID: 26368842 DOI: 10.1111/sji.12390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
48 Frey M, Bobbala S, Karabin N, Scott E. Influences of nanocarrier morphology on therapeutic immunomodulation. Nanomedicine (Lond) 2018;13:1795-811. [PMID: 30084296 DOI: 10.2217/nnm-2018-0052] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
49 Meier HCS, Haan MN, Mendes de Leon CF, Simanek AM, Dowd JB, Aiello AE. Early life socioeconomic position and immune response to persistent infections among elderly Latinos. Soc Sci Med 2016;166:77-85. [PMID: 27543684 DOI: 10.1016/j.socscimed.2016.07.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
50 Bravo D, Hoare A, Soto C, Valenzuela MA, Quest AF. Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects. World J Gastroenterol 2018; 24(28): 3071-3089 [PMID: 30065554 DOI: 10.3748/wjg.v24.i28.3071] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 45] [Article Influence: 13.3] [Reference Citation Analysis]
51 Liu M, Zhong Y, Chen J, Liu Y, Tang C, Wang X, Zhang Y, Wang P, Logan SM, Chen W, Wei B. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection. Vaccine 2020;38:3031-41. [PMID: 32139315 DOI: 10.1016/j.vaccine.2020.02.036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
52 Li H, Liang D, Hu N, Dai X, He J, Zhuang H, Zhao W. Helicobacter pylori inhibited cell proliferation in human periodontal ligament fibroblasts through the Cdc25C/CDK1/cyclinB1 signaling cascade. J Periodontal Implant Sci 2019;49:138-47. [PMID: 31285938 DOI: 10.5051/jpis.2019.49.3.138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
53 Ansari H, Tahmasebi-Birgani M, Bijanzadeh M. DNA vaccine containing Flagellin A gene induces significant immune responses against Helicobacter pylori infection: An in vivo study. Iran J Basic Med Sci 2021;24:796-804. [PMID: 34630957 DOI: 10.22038/ijbms.2021.54415.12227] [Reference Citation Analysis]
54 Lian DW, Xu YF, Ren WK, Fu LJ, Chen FJ, Tang LY, Zhuang HL, Cao HY, Huang P. Unraveling the Novel Protective Effect of Patchouli Alcohol Against Helicobacter pylori-Induced Gastritis: Insights Into the Molecular Mechanism in vitro and in vivo. Front Pharmacol 2018;9:1347. [PMID: 30524287 DOI: 10.3389/fphar.2018.01347] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
55 Gurtner A, Gonzalez-Perez I, Arnold IC. Intestinal eosinophils, homeostasis and response to bacterial intrusion. Semin Immunopathol 2021;43:295-306. [PMID: 33929602 DOI: 10.1007/s00281-021-00856-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]